PHARMACEUTICAL COMPOSITION COMPRISING THE PDE4 ENZYME INHIBITOR REVAMILAST AND A DISEASE MODIFYING AGENT, PREFERABLY METHOTREXATE
摘要
<p>The present patent application relates to a pharmaceutical composition comprising a PDE4 enzyme inhibitor and a disease modifying agent; a process for preparing such composition; and its use in treating an autoimmune disease in a subject.</p>
